Veterinary Healthcare Market By Product Type (Drugs (Antibiotics, Antifungal, Ectoparasiticides, Endoparacitides, Endectoparaciticides, Anti-inflammatory Drugs, Drugs for Chronic Diseases, and Others), Vaccines, and Feed Additives (Nutritional Feed Additives and Medicinal Feed Additives)), By Animal Type (Farm Animals (Livestock, Poultry, Swine, and Equine) Companion Animals (Feline, Canine, and Avian), and Aquaculture), By Route of Administration (Oral, Parenteral, Topical, and Others), Distribution Channel (Veterinary Pharmacies, Veterinary Hospitals, Veterinary Clinics, and E-Commerce), and Geography


Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

The global veterinary healthcare market size estimated to be valued US$ 37.4 Bn in 2020 at CAGR of 4.9% and expected to reach US$ 49.3 Bn by 2026 due to increased adoption of companion animals in emerging and developed countries and rising consumption of meat across the globe. The rising adoption of companion animals in emerging countries and increasing consumption of meat for dietary needs expected to fuel the market for animal healthcare products over the forecast period. Apart from aforementioned dynamics, factors like increased instances of disease outbreaks in animals, and large-scale production of animals in the form of factory farming expected to boost the animal healthcare market. Animals have long been considered as a source of food for the human being and it’s been shifting towards companionship to the humans. As there is a growing interaction between humans and animals prompting the key stakeholders to give attention to animal healthcare. The rising incidences of zoonotic disease in several developed and developing countries expected to create demand for animal healthcare products like drugs and vaccines over the forecast period. According to U.S. Centre for disease control and Prevention (CDC) every year tens of thousands of people get sick due to disease spread from animals to humans and it is believed that more than six out of every 10 known infectious diseases in people are spread from animals, and three out of every four new or emerging infectious diseases in people are spread from animals, which can be prevented by appropriate health care to animals. In addition, This report includes animal demographics; regulatory scenario, top meat-producing countries, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed veterinary healthcare market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities).

Veterinary Healthcare Market Summary

Study Period


Base Year




Largest Market

North America

Fastest Growing Market

Asia Pacific
Veterinary Healthcare Market Dynamics

A huge growth in global demand for protein food, as well as an increase in the frequency of zoonotic and food-borne diseases, are driving the industry. Companies have been spurred to develop enhanced vaccines and medications as a result of the enormous growth in disease prevalence. As a result of the increasing demand, there has been an increase in the number of companies making regular efforts to control pathogen contamination concerns and food-borne diseases, which is helping to drive market expansion.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Veterinary Healthcare Market Segmentation

By Product Type
  • Drugs
    • Antibiotics
    • Antifungal
    • Ectoparasiticides
    • Endoparasites
    • Endectoparaciticides
    • Anti-inflammatory Drugs
    • Drugs for Chronic Diseases
    • Others
  • Vaccines
  • Feed Additives
    • Nutritional Feed Additives
    • Medicinal Feed Additives
By Animal Type
  • Farm Animals
    • Livestock
    • Poultry
    • Swine
    • Equine
  • Companion Animals
    • Feline
    • Canine
    • Avian
  • Aquaculture
Route Administration
  • Oral
  • Parenteral
  • Topical
  • Others
Distribution Channel
  • Veterinary Pharmacies
  • Veterinary Hospitals
  • Veterinary Clinics
  • E-Commerce

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

[urltag url='request-table-of-content']

  • Bayer AG (Germany)
  • Boehringer Ingelheim GmbH (Germany)
  • Cargill, Inc. (U.S)
  • Ceva Santé Animale (France)
  • Eli Lilly and Company (U.S)
  • Koninklijke DSM N.V. (Netherlands)
  • Merck & Co., Inc. (U.S)
  • Novartis AG (Switzerland)
  • Nutreco N.V. (Netherlands)
  • SeQuent Scientific Ltd. (India)
  • Vétoquinol S.A. (France)
  • Virbac S.A. (France)
  • Zoetis Inc. (U.S)